Monthly Archives: May 2019

A vigorous debate is occurring at the WHA in Geneva over the need for R&D cost transparency leading to availability of medicines at affordable prices.  Italy has submitted a resolution that is supported by some, modified by others and opposed … Continue reading →

More than 30 treatment activist organisations, public health organisation and patients have signed on to a letter to India’s Health Minister explaining the pitfalls of ad hoc donations from Pharmaceutical companies. They call for the MOHFW to put in place … Continue reading →